A recent study by the French League Against Cancer has revealed that nearly half (50.6%) of cancer patients were not consulted about their radiotherapy treatment, a widely used method for treating various types of cancer. The research, based on responses from 3,669 patients, also found that over a quarter (28.5%) said their consent was not sought before undergoing the treatment. The study uncovered notable differences between men and women, with 37.3% of women reporting their consent was not requested, compared to 17.1% of men. Similarly, 64% of women said their opinions on treatment were not sought, compared to 33% of men. The research also highlighted a lack of information about the potential side effects of radiotherapy. Approximately 27% of patients were not informed about the risks or side effects associated with the treatment. Despite 88% of patients experiencing at least one adverse effect—such as fatigue, burns, digestive issues, and oral or dental problems—more than a third of them did not receive any supportive care to help manage these effects. Furthermore, nearly one in five (24.4%) patients were not informed about what would happen after their treatment ended, even though 83% of those surveyed continued to experience side effects long after treatment concluded. Catherine Simonin, president of the health policy commission at the French League Against Cancer, stressed the importance of fully informing patients and involving them in treatment decisions. She noted that while medical advancements have been significant, there is still a gap in ensuring patients understand their treatments, the possible side effects, and the support services available to them. Patients like Nadia Mahituku, who received radiotherapy for breast cancer, and Jacques, who underwent treatment for throat cancer, expressed regret over not being adequately informed about their options and the potential side effects. Nadia wished she had known about the permanent marks left by the treatment and the possibility of alternative methods. Jacques felt his choice was taken away and expressed frustration over the lack of preparation for the treatment's effects. Sylvie Negrier, an oncologist and president of the French Society of Oncology, acknowledged the critical role of radiotherapy in cancer treatment. However, she noted that patients often become aware of the treatment’s implications only after it has started. She emphasized the need for better communication and greater patient involvement in making treatment decisions, even as the benefits of radiotherapy remain clear.